Salvatore Putignano

437 total citations
16 papers, 267 citations indexed

About

Salvatore Putignano is a scholar working on Neurology, Pharmacology and Physiology. According to data from OpenAlex, Salvatore Putignano has authored 16 papers receiving a total of 267 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Neurology, 4 papers in Pharmacology and 4 papers in Physiology. Recurrent topics in Salvatore Putignano's work include Neurological Disorders and Treatments (13 papers), Neurological Disease Mechanisms and Treatments (9 papers) and Cholinesterase and Neurodegenerative Diseases (4 papers). Salvatore Putignano is often cited by papers focused on Neurological Disorders and Treatments (13 papers), Neurological Disease Mechanisms and Treatments (9 papers) and Cholinesterase and Neurodegenerative Diseases (4 papers). Salvatore Putignano collaborates with scholars based in Italy, United States and Belarus. Salvatore Putignano's co-authors include Antonino Maria Cotroneo, Pietro Gareri, Alberto Castagna, Amalia C. Bruni, Giovambattista De Sarro, Roberto Lacava, Fausto Fantò, Francesco Monteleone, Alba Malara and Giuseppe Orsitto and has published in prestigious journals such as Age and Ageing, Journal of Alzheimer s Disease and Alzheimer s & Dementia.

In The Last Decade

Salvatore Putignano

15 papers receiving 259 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Salvatore Putignano 187 75 48 42 30 16 267
Victor Pichel 136 0.7× 78 1.0× 95 2.0× 45 1.1× 40 1.3× 10 290
Beatriz Sonai 130 0.7× 62 0.8× 43 0.9× 11 0.3× 64 2.1× 7 316
Somayeh Rostamian 41 0.2× 44 0.6× 60 1.3× 44 1.0× 66 2.2× 17 260
А. Yu. Emelin 103 0.6× 34 0.5× 42 0.9× 70 1.7× 20 0.7× 40 268
Kai‐Ming Duan 73 0.4× 39 0.5× 21 0.4× 24 0.6× 46 1.5× 9 303
Maria Eduarda Fileti 93 0.5× 19 0.3× 33 0.7× 18 0.4× 94 3.1× 7 346
Kazumasa Kume 67 0.4× 47 0.6× 131 2.7× 116 2.8× 61 2.0× 9 313
Naiana da Rosa 109 0.6× 15 0.2× 37 0.8× 18 0.4× 89 3.0× 11 369
Rajesh Kalaria 179 1.0× 42 0.6× 93 1.9× 40 1.0× 71 2.4× 6 316
Michael Tribanek 124 0.7× 31 0.4× 68 1.4× 65 1.5× 16 0.5× 8 238

Countries citing papers authored by Salvatore Putignano

Since Specialization
Citations

This map shows the geographic impact of Salvatore Putignano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Salvatore Putignano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Salvatore Putignano more than expected).

Fields of papers citing papers by Salvatore Putignano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Salvatore Putignano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Salvatore Putignano. The network helps show where Salvatore Putignano may publish in the future.

Co-authorship network of co-authors of Salvatore Putignano

This figure shows the co-authorship network connecting the top 25 collaborators of Salvatore Putignano. A scholar is included among the top collaborators of Salvatore Putignano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Salvatore Putignano. Salvatore Putignano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Gareri, Pietro, et al.. (2024). Citicoline: A Cholinergic Precursor with a Pivotal Role in Dementia and Alzheimer’s Disease. Journal of Alzheimer s Disease. 100(2). 725–733. 3 indexed citations
2.
Putignano, Salvatore, et al.. (2024). Early Detection Screening of Cognitive Decline in Patients Over 60 Years: ELDERCARE Study. Journal of Alzheimer s Disease. 98(1). 145–150.
3.
Gareri, Pietro, Antonino Maria Cotroneo, Giuseppe Orsitto, Nicola Veronese, & Salvatore Putignano. (2022). The CITIDEMAGE Study: Combined Treatment with a Cholinergic Precursor in Dementia Patients. 6(1). 1–25. 1 indexed citations
4.
Gareri, Pietro, Antonino Maria Cotroneo, Giuseppe Orsitto, & Salvatore Putignano. (2020). The CITIMEM study: A pilot study. Optimizing pharmacological treatment in dementia. Archives of Gerontology and Geriatrics. 89. 104073–104073. 13 indexed citations
5.
Gareri, Pietro, Antonino Maria Cotroneo, Giuseppe Orsitto, & Salvatore Putignano. (2020). The Importance of Citicoline in Combined Treatment in Dementia: What did the Citimem Study Teach us?. Reviews on Recent Clinical Trials. 16(2). 126–130. 1 indexed citations
6.
Gareri, Pietro, Antonino Maria Cotroneo, Giuseppe Orsitto, & Salvatore Putignano. (2020). The CITIDEMAGE Study: Stressing the cholinergic hypothesis for the best outcomes in dementia patients. Alzheimer s & Dementia. 16(S9). 3 indexed citations
8.
Manzo, Ciro, Alberto Castagna, Ernesto Palummeri, et al.. (2016). Livelli di 25(OH)D e performance cognitive in una popolazione di anziani: lo studio COGNIDAGE. Recenti Progressi in Medicina. 107(2). 75–83. 6 indexed citations
9.
Gareri, Pietro, et al.. (2016). The Citicholinage Study: Citicoline Plus Cholinesterase Inhibitors in Aged Patients Affected with Alzheimer’s Disease Study. Journal of Alzheimer s Disease. 56(2). 557–565. 44 indexed citations
10.
Manzo, Ciro & Salvatore Putignano. (2015). Drug-induced lupus erythematosus associated with donepezil: a case report. Age and Ageing. 44(6). 1062–1063. 2 indexed citations
11.
Gareri, Pietro, Alberto Castagna, Antonino Maria Cotroneo, et al.. (2015). The role of citicoline in cognitive impairment: pharmacological characteristics, possible advantages, and doubts for an old drug with new perspectives. Clinical Interventions in Aging. 10. 1421–1421. 71 indexed citations
12.
Gareri, Pietro, Alberto Castagna, Antonino Maria Cotroneo, et al.. (2014). Retrospective Study on the Benefits of Combined Memantine and cholinEsterase inhibitor treatMent in AGEd Patients affected with Alzheimer's Disease: The MEMAGE Study. Journal of Alzheimer s Disease. 41(2). 633–640. 22 indexed citations
13.
Gareri, Pietro, Alberto Castagna, Roberto Lacava, et al.. (2014). P2‐086: CITICOLINE IN COGNITIVE IMPAIRMENT: AN OLD DRUG WITH NEW PERSPECTIVES. Alzheimer s & Dementia. 10(4S_Part_13). 1 indexed citations
14.
Gareri, Pietro, Antonino Maria Cotroneo, Alberto Castagna, et al.. (2013). Effectiveness and safety of citicoline in mild vascular cognitive impairment: the IDEALE study. Clinical Interventions in Aging. 8. 131–131. 71 indexed citations
15.
16.
Cotroneo, Antonino Maria, Salvatore Putignano, Fausto Fantò, et al.. (2012). O4‐12‐05: Effectiveness and safety of citicoline in mild vascular cognitive impairment: The IDEALE study. Alzheimer s & Dementia. 8(4S_Part_20). 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026